This book explores how genetic variants influence drug transporter proteins and their impact on pharmacokinetics. It covers key transporter genes like ABC and SLC families that affect drug absorption, distribution, and excretion. The book emphasizes the role of transporter polymorphisms in personalized medicine and drug dosing. Suitable for pharmacologists and geneticists, it highlights the importance of transporters in drug response variability.
Olivia Burns investigates gene variants that affect drug transporter proteins, influencing the efficacy and safety of dermatological medications. Her research focuses on how genetic polymorphisms in transporters impact the absorption and distribution of skin treatments for conditions like psoriasis and acne. Olivia has authored numerous studies on identifying genetic markers that predict transporter functionality and patient responses to therapies. She also offers guidelines for clinicians to utilize pharmacogenomic insights in managing drug transporter interactions, promoting safer and more effective dermatological treatments through personalized medicine approaches.